|
|
|
|
|
|
Alexion Pharm Inc (ALXN)
|
|
130.74 -1.05 (-0.80%)
|
7/24/2017 4:00pm
|
|
Open:
|
132.03
|
Pre. Close:
|
131.79
|
|
High:
|
132.22
|
Low:
|
130.19
|
|
Volume:
|
1,749,521
|
Market Cap:
|
29.36B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
132.79 - 134.37
|
134.37 - 135.54
|
|
Low:
|
127 - 128.52
|
128.52 - 129.64
|
|
Close:
|
129 - 131.24
|
131.24 - 132.88
|
|
|
|
|
|
|
Technical analysis (as of: 2017-07-24 4:33:41 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 154.43  One year: 180.38
|
|
Support:
|
Support1: 120.48 Support2: 113.22
|
|
Resistance:
|
Resistance1:
132.22 Resistance2: 154.43
|
|
Pivot:
|
125.94
|
|
Moving Averages:
|
MA(5): 129.28 MA(20): 125.31
MA(100): 119.46 MA(250): 124.19
|
|
MACD:
|
MACD(12,26):
3.52 Signal(12,26,9): 3.22
|
|
%K %D:
|
%K(14,3): 95.76 %D(3): 92.78
|
|
RSI:
|
RSI(14): 65.90
|
|
52-Week:
|
High: 145.41
Low: 96.18 Change(%): 3.2
|
|
Average Vol(K):
|
3-Month: 315555
10-Days 124826
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.ALXN has closed below upper band by 10.9%. Bollinger Bands are 30.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Fri, 16 Jun 2017 17:26:15 GMT
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Expected to Post Quarterly Sales ...
Wed, 19 Jul 2017 20:59:26 GMT
Upcoming Soliris Catalyst Offers Hope For Battered Alexion Stock
Thu, 06 Jul 2017 20:05:18 GMT
Alexion Pharmaceuticals reportedly under investigation by HHS
Fri, 07 Jul 2017 15:56:15 GMT
Alexion Pharmaceuticals: Nothing to See Here?
Mon, 24 Jul 2017 14:26:15 GMT
Why Investors remained buoyant on: Alexion Pharmaceuticals, Inc. (ALXN), MFA ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
